Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future

In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.

Related Keywords

New York ,United States ,Columbia University ,American ,Paul Appelbaum ,American Psychiatric Association ,Drug Administration ,Psychedelic Compounds ,Assisted Therapy ,Therapeutic Psilocybin Are ,Psychedelics ,